BackgroundAnalyses of brain samples from Alzheimer’s disease (AD) patients may be expected to help us improve our understanding of the pathogenesis of AD. Bioactive lipids, including sphingolipids, glycerophospholipids, and eicosanoids/related mediators have been demonstrated to exert potent physiological actions and to be involved in the pathogenesis of various human diseases. In this cross-sectional study, we attempted to elucidate the associations of these bioactive lipids with the pathogenesis/pathology of AD through postmortem studies of human brains.MethodsWe measured the levels of glycerophospholipids, sphingolipids, and eicosanoids/related mediators in the brains of patients with AD (AD brains), patients with Cerad score B (Cerad-b ...
The development of plasma biomarkers could facilitate early detection, risk assessment and therapeut...
Advances in high performance liquid chromatography-electrospray ionization-mass spectrometry made in...
Alzheimer’s disease (AD) is a neurodegenerative disorder that causes severe and progressive cognitiv...
Alzheimer’s disease (AD) is reported to be closely linked with abnormal lipid metabolism. To gain a ...
Alzheimer’s disease (AD) is a debilitating neurodegenerative disease and a significant burden on fam...
Abstract: Alzheimer’s disease (AD) is the leading cause of dementia worldwide giving rise to devasta...
Alzheimer’s disease (AD) is a progressive neurodegenerative disease which affects a growing number o...
International audienceBACKGROUND:There are now significant evidences that lipid metabolism is affect...
Introduction: Comorbidity with metabolic diseases indicates that lipid metabolism plays a role in th...
WOS: 000253935100002PubMed ID: 18288926Advances in Alzheimer Disease (AD) research suggest that cent...
Purpose of review Alzheimer's disease is the most common cause of dementia. There are still no disea...
Lipids are not only constituents of cellular membranes, but they are also key signaling mediators, t...
Alzheimer's disease (AD) is the leading cause of dementia in the elderly. Mutations in genes encodin...
Brain is one of the richest organs in lipid content. Phospholipids (glycerophospholipids and sphingo...
Lipid dyshomeostasis is associated with the most common form of dementia, Alzheimer's disease (AD). ...
The development of plasma biomarkers could facilitate early detection, risk assessment and therapeut...
Advances in high performance liquid chromatography-electrospray ionization-mass spectrometry made in...
Alzheimer’s disease (AD) is a neurodegenerative disorder that causes severe and progressive cognitiv...
Alzheimer’s disease (AD) is reported to be closely linked with abnormal lipid metabolism. To gain a ...
Alzheimer’s disease (AD) is a debilitating neurodegenerative disease and a significant burden on fam...
Abstract: Alzheimer’s disease (AD) is the leading cause of dementia worldwide giving rise to devasta...
Alzheimer’s disease (AD) is a progressive neurodegenerative disease which affects a growing number o...
International audienceBACKGROUND:There are now significant evidences that lipid metabolism is affect...
Introduction: Comorbidity with metabolic diseases indicates that lipid metabolism plays a role in th...
WOS: 000253935100002PubMed ID: 18288926Advances in Alzheimer Disease (AD) research suggest that cent...
Purpose of review Alzheimer's disease is the most common cause of dementia. There are still no disea...
Lipids are not only constituents of cellular membranes, but they are also key signaling mediators, t...
Alzheimer's disease (AD) is the leading cause of dementia in the elderly. Mutations in genes encodin...
Brain is one of the richest organs in lipid content. Phospholipids (glycerophospholipids and sphingo...
Lipid dyshomeostasis is associated with the most common form of dementia, Alzheimer's disease (AD). ...
The development of plasma biomarkers could facilitate early detection, risk assessment and therapeut...
Advances in high performance liquid chromatography-electrospray ionization-mass spectrometry made in...
Alzheimer’s disease (AD) is a neurodegenerative disorder that causes severe and progressive cognitiv...